Technical Analysis for IMC - Immuron Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 2.22% | |
| New Uptrend | Bullish | 2.22% | |
| Lower Bollinger Band Walk | Weakness | 2.22% | |
| Bullish Engulfing | Bullish | 2.22% | |
| Stochastic Reached Oversold | Weakness | 2.22% | |
| Below Lower BB | Weakness | 2.22% | |
| Gapped Down | Weakness | 2.22% | |
| Oversold Stochastic | Weakness | 2.22% | |
| New Downtrend | Bearish | 3.37% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 5 hours ago |
| Up 2% | about 8 hours ago |
| Up 3% | about 8 hours ago |
| Up 1% | about 9 hours ago |
| Up 5% | 1 day ago |
Free Daily (Stock) Chart Reading
Immuron Limited Description
Immuron Limited is a biopharmaceutical company. The Company focuses on the research and development of bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infections and immune modulated diseases. The Company has three segments: Research and Development (R&D), HyperImmune Products and Corporate. The R&D segment focuses on the Company's research and development projects performed in Australia and Israel. The Company sells and licenses its product, Travelan. The HyperImmune Products segment is engaged in its Travelan product's activities, which occur in Australia, New Zealand and Canada. The Corporate segment's activities primarily occur in Australia. It also develops products for applications, including non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH) and clostridium difficile (C-Diff), diabetes, colitis and uropathogenic escherichia coli (UPEC). The Company also offers Protectyn, IMM 124-E-NASH and IMM 529-CDI.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Disease Travel Diseases Biopharmaceutical Medical Specialties Prevention Infection Diabetes Infectious Diseases Hepatitis Infections Antibodies Colostrum Steatohepatitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.17 |
| 52 Week Low | 0.065 |
| Average Volume | 1,774,187 |
| 200-Day Moving Average | 0.083 |
| 50-Day Moving Average | 0.103 |
| 20-Day Moving Average | 0.098 |
| 10-Day Moving Average | 0.095 |
| Average True Range | 0.005 |
| RSI (14) | 42.20 |
| ADX | 24.16 |
| +DI | 33.469 |
| -DI | 30.623 |
| Chandelier Exit (Long, 3 ATRs) | 0.089 |
| Chandelier Exit (Short, 3 ATRs) | 0.100 |
| Upper Bollinger Bands | 0.108 |
| Lower Bollinger Band | 0.088 |
| Percent B (%b) | 0.19 |
| BandWidth | 20.346 |
| MACD Line | -0.003 |
| MACD Signal Line | -0.002 |
| MACD Histogram | -0.0012 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.097 | ||||
| Resistance 3 (R3) | 0.097 | 0.095 | 0.096 | ||
| Resistance 2 (R2) | 0.095 | 0.094 | 0.095 | 0.095 | |
| Resistance 1 (R1) | 0.094 | 0.093 | 0.095 | 0.094 | 0.095 |
| Pivot Point | 0.092 | 0.092 | 0.093 | 0.092 | 0.092 |
| Support 1 (S1) | 0.091 | 0.091 | 0.092 | 0.091 | 0.089 |
| Support 2 (S2) | 0.089 | 0.090 | 0.089 | 0.089 | |
| Support 3 (S3) | 0.088 | 0.089 | 0.088 | ||
| Support 4 (S4) | 0.088 |
